Search Results - "Bodner, W.R."

Local Control After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Tale of 2 Schedules? by Lee, A, Ohri, N, Purswani, J, Yaparpalvi, R, Bodner, W.R, Garg, M.K, Kalnicki, S

Get full text

Continuous Activity Monitoring During Concurrent Chemoradiation Therapy by Ohri, N, Kabarriti, R, Bodner, W.R, Mehta, K.J, Halmos, B, Haigentz, M, Rapkin, B, Guha, C, Kalnicki, S, Garg, M.K

Get full text

Can Intensity Modulated Proton Therapy (IMPT) Be an Alternative to Image Guided Brachytherapy (IGBT) for Locally Advanced Cervical Cancer? by Kuo, H.C, Mehta, K.J, Yaparpalvi, R, Garg, M, Bodner, W.R, Ho, M.W, Tome, W.A, Kalnicki, S

Get full text

Real-World Dose Delivery Accuracy of Prostate SBRT with Tomotherapy Based Target Tracking by Goddard, L., Tang, J., Garg, M.K., III, W.R. Bodner, Brodin, P., Jeong, K., Tome, W.A.

Get full text

Definitive Radiotherapy without Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Modern Experience by Berkowitz, A.C., Bodner, W.R., Cheng, H., Halmos, B., Ohri, N.

Get full text

Does Adjuvant Durvalumab Improve Local Control Following Chemoradiotherapy for Non-Small Cell Lung Cancer? by Zakharia, A., III, W.R. Bodner, Halmos, B., Garg, M.K., Gucalp, R., Cheng, H., Stiles, B.M., Ohri, N.

Get full text

Financial Toxicity Predicts Survival Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer in a Socioeconomically Diverse Population by Klein, J., Bodner, W.R., Garg, M.K., Kalnicki, S., Ohri, N.

Get full text

Cardiac Dosing Predicts Activity Decline During Concurrent Chemoradiation for Locally Advanced Lung Cancer by Paul, S., Bodner, W.R., Garg, M.K., Ohri, N.

Get full text

Who Benefits Most from Adjuvant Durvalumab after Chemoradiotherapy for Non-Small Cell Lung Cancer? by Ohri, N., Halmos, B., Bodner, W.R., Cheng, H., Garg, M.K., Gucalp, R., Guha, C.

Get full text

Predictors of Early Durvalumab Discontinuation After Chemoradiotherapy for Non-Small Cell Lung Cancer by Pennock, M.M., Halmos, B., III, W.R. Bodner, Cheng, H., Gucalp, R., Ohri, N.

“…Based on the PACIFIC trial, adjuvant durvalumab is now recommended after concurrent chemoradiotherapy (CRT) for locally advanced non–small cell lung cancer…”
Get full text

The Selective Personalized Radioimmunotherapy for Locally Advanced NSCLC Trial (SPRINT): Patient-Reported Outcomes by Ohri, N., Jolly, S., Cooper, B., Kabarriti, R., Bodner, W.R., Guha, C., Viswanathan, S., Shum, E., Sabari, J.K., Cheng, H., Gucalp, R., Castellucci, E., Qin, A., Gadgeel, S.M., Halmos, B.

“…Initial reports from the Selective Personalized Radioimmunotherapy for Locally Advanced NSCLC Trial (SPRINT) indicated that patients with high PD-L1 expression…”
Get full text

Predictors of Overall Survival Following Disease Progression After Definitive Chemoradiation Therapy for Non–Small Cell Lung Cancer by Paul, S., Bodner, W.R., Garg, M.K., Ohri, N.

Get full text

Comparing Photon and Proton Based Hypofractioned SBRT for Prostate Cancer Accounting for Robustness and Realistic Treatment Deliverability by Goddard, L., Brodin, P., Garg, M.K., Tome, W.A., Bodner, W.R.

Get full text

Are Patients Distressed? A Prospective Study on Sources of Distress in Ethnically Diverse and Economically Disadvantaged Cancer Patients by Jiang, J.M., Haynes-Lewis, H., Kabarriti, R., Bodner, W.R., Ohri, N., Mo, A., Tang, J., Mehta, K.J., Moadel-Robblee, A., Guha, C., Kalnicki, S., Garg, M.K.

Get full text

Daily Step Counts Predict Outcomes for Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy by Ohri, N., Halmos, B., Bodner, W.R., Cheng, H., Guha, C., Kalnicki, S., Garg, M.K.

Get full text

The Effect of Afternoon Treatment on Post-Treatment Lymphopenia in Locally Advanced NSCLC Patients Receiving Definitive Chemoradiation Therapy by Tang, J., Bodner, W.R., Halmos, B., Cheng, H., Guha, C., Ohri, N.

Get full text

Real-time Activity Monitoring to Prevent Admissions during Radiotherapy (RAMPART) by Andraos, T.Y., Asaro, A.M., Garg, M.K., Bodner, W.R., Kabarriti, R., Zanartu, C., Kalnicki, S., Ohri, N.

Get full text

The Feasibility of Simultaneous Integrated Boost to Dominant Intra-Prostatic Lesions (DIL) in Prostate Stereotactic Body Radiation Therapy (SBRT) by Tang, J., Goddard, L., Brodin, P., Bodner, W.R., Guha, C., Kalnicki, S., Tome, W.A., Garg, M.K.

Get full text

The Relationship Between Financial Toxicity and Missed Radiation Appointments Among Patients Receiving Concurrent Radiation and Chemotherapy by Jiang, J.M., Ohri, N., Bodner, W.R., Fox, J.L., Garg, M.K., Kabarriti, R., Kalnicki, S., Mehta, K.J., Tang, J., Yap, J., Klein, J.

Get full text

Predictors of Financial Toxicity in Patients Receiving Concurrent Radiation and Chemotherapy by Jiang, J.M., Eichler, J., Bodner, W.R., Fox, J.L., Garg, M.K., Kabarriti, R., Kalnicki, S., Mehta, K.J., Rivera, A., Tang, J., Yap, J., Ohri, N., Klein, J.

“…Financial toxicity (FT) is an increasingly recognized concern for cancer patients. We reviewed prospectively collected data to explore factors associated with…”
Get full text